2563 — Beijing Biostar Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- HK$1.48bn
- HK$929.82m
- CNY33.36m
Brief: Beijing Biostar Pharmaceuticals Says Board Resolves To Repurchase H Shares In Open Market
Brief: Beijing Biostar Pharmaceuticals Posts FY Loss Attributable RMB131.4 Mln
Brief: FDA Grants Orphan Drug Designation To Biostar Pharma's Utidelone
Brief: Biostar Pharma Doses First Patients In Two Phase II/III Global Trials Of Utidelone Capsule (UTD2) For Cancer
Brief: Beijing Biostar Pharmaceuticals Posts FY Loss Attributable Of RMB143.8 Mln
Brief: Beijing Biostar Pharmaceuticals Sees Net Loss Of RMB146 Mln To RMB151 Mln For Year
Brief: Beijing Biostar Pharmaceuticals Announces Approval Of Utidelone Capsule By U.S. FDA
Brief: Beijing Biostar Pharmaceuticals Says To Grant Baheal Zhihe Exclusive Marketing Rights
Brief: Beijing Biostar Pharmaceuticals Announces Final Offer Price Under Global Offering